27. 1. 2021
Today’s press conference on the current situation regarding COVID-19 was attended by Nuška Čakš Jager, Deputy Head of the Centre for Communicable Diseases at the National Institute of Public Health, and Tjaša Žohar Čretnik, Director of the National Laboratory of Health, Environment and Food. Deputy Head of the Centre for Communicable Diseases at the National Institute of Public Health Nuška Čakš Jager |
Author Daniel Novaković, STA
With 5,418 PCR tests performed yesterday, 1,430 were positive, which amounts to 26.4 per cent. With 10,528 rapid antigen tests, 420 were positive, which is almost 4 per cent. The total number of tests amounts to 15,964, of which 1,850 were positive, i.e. almost 200 more than on Monday. Some 1,144 patients were in hospitals yesterday (1,157 on Monday), of whom 172 required intensive care, 20 fewer than a day before. Some 19 people have died in hospitals. The average of confirmed cases in the last seven days at th
BRUSSELS
Belgium’s Consultation Committee, which includes representatives of the various governments of the country, is set to examine whether a ban on non-essential travel could be imposed in the absence of an EU-wide solution after the EU summit on Thursday. Read more.
///
BERLIN
Germany wants to talk Nord Stream 2 with Biden administration. German Chancellor Angela Merkel aims to discuss the Nord Stream 2 gas pipeline with the Biden administration after US sanctions against companies participating in the project went into effect this week. Read more.
///
PARIS
French health minister defends vaccination strategy. “Before the end of January, we will have carried out 1.3 or 1.4 million vaccinations, more than the one million we announced,” French Health Minister Olivier Véran said on TF1’s evening news Thursday in defence of his government’s vaccine strategy, which had been criticised for its slowness. Read more.
Slovenia Times
7. January, 2021
Ljubljana – The Agency for Medicinal Products and Medical Devices has decided to carry out an extraordinary inspection of the suitability of the rapid antigen tests the Health Ministry purchased in December from the company Majbert Pharm. The decision comes after suspicion has been raised in the public about the reliability of these tests.
“As this is a large-scale activity that may be connected with risks, we have – as is required by law – decided to carry out inspection … to examine the compliance of the supplied medical device with legislative requirements,” the agency said on Wednesday.
It added that the scope and duration of inspection could not be estimated at the moment, as this would depend on the findings made during the inspection.